PM2 supports the classification at Supporting strength because the variant is absent from gnomAD v2.1 and v4.1.
This variant was interpreted by pipeline 11.0.06. The current version is 11.0.07. Re-running queues a fresh interpretation; the result replaces this page when complete.
Re-runs are not free. Blank = draws on today's public interpretation allowance. With a code = uses 1 of that code's uses.
PTEN is a tumor suppressor gene that encodes a phosphatase converting the lipid messenger PIP3 back to PIP2 at the cell membrane, thereby restraining the AKT/mTOR signaling pathway that drives cell growth, proliferation, and survival. It is one of the most frequently mutated genes across many types of human cancer, and its loss promotes unchecked cell growth, survival, and genomic instability, partly through impaired DNA repair. Germline loss-of-function variants in PTEN cause Cowden syndrome, an inherited cancer predisposition disorder associated with elevated risk of breast and thyroid cancer.
As a noncoding PTEN variant, this change is relevant to assessment of a tumor-suppressor gene in which germline loss of function causes Cowden syndrome and related cancer predisposition.
PM2 supports the classification at Supporting strength because the variant is absent from gnomAD v2.1 and v4.1.